263 related articles for article (PubMed ID: 22184113)
21. Differential regulation of estrogen receptor α expression in breast cancer cells by metastasis-associated protein 1.
Kang HJ; Lee MH; Kang HL; Kim SH; Ahn JR; Na H; Na TY; Kim YN; Seong JK; Lee MO
Cancer Res; 2014 Mar; 74(5):1484-94. PubMed ID: 24413532
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of MTA1 promotes invasiveness and metastasis of ovarian cancer cells.
He X; Zhou C; Zheng L; Xiong Z
Ir J Med Sci; 2014 Sep; 183(3):433-8. PubMed ID: 24214543
[TBL] [Abstract][Full Text] [Related]
23. MTA1 drives malignant progression and bone metastasis in prostate cancer.
Kumar A; Dhar S; Campanelli G; Butt NA; Schallheim JM; Gomez CR; Levenson AS
Mol Oncol; 2018 Sep; 12(9):1596-1607. PubMed ID: 30027683
[TBL] [Abstract][Full Text] [Related]
24. MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer.
Zhou N; Wang H; Liu H; Xue H; Lin F; Meng X; Liang A; Zhao Z; Liu Y; Qian H
J Exp Clin Cancer Res; 2015 Dec; 34():157. PubMed ID: 26698569
[TBL] [Abstract][Full Text] [Related]
25. Crosstalk between ATF4 and MTA1/HDAC1 promotes osteosarcoma progression.
Zeng H; Zhang JM; Du Y; Wang J; Ren Y; Li M; Li H; Cai Z; Chu Q; Yang C
Oncotarget; 2016 Feb; 7(6):7329-42. PubMed ID: 26797758
[TBL] [Abstract][Full Text] [Related]
26. Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer cell invasion, proliferation and nuclear regulation.
Nicolson GL; Nawa A; Toh Y; Taniguchi S; Nishimori K; Moustafa A
Clin Exp Metastasis; 2003; 20(1):19-24. PubMed ID: 12650603
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic silencing of RNF144A expression in breast cancer cells through promoter hypermethylation and MBD4.
Zhang Y; Yang YL; Zhang FL; Liao XH; Shao ZM; Li DQ
Cancer Med; 2018 Apr; 7(4):1317-1325. PubMed ID: 29473320
[TBL] [Abstract][Full Text] [Related]
28. microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1.
Zhou H; Xu X; Xun Q; Yu D; Ling J; Guo F; Yan Y; Shi J; Hu Y
Oncol Rep; 2012 Mar; 27(3):807-12. PubMed ID: 22139444
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of MTA1 protein leads to the inhibition of migration, invasion, and angiogenesis of non-small-cell lung cancer cell line.
Li S; Tian H; Yue W; Li L; Gao C; Si L; Li W; Hu W; Qi L; Lu M
Acta Biochim Biophys Sin (Shanghai); 2013 Feb; 45(2):115-22. PubMed ID: 23343746
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of metastasis-associated MTA1 in oral squamous cell carcinomas: correlation with metastasis and invasion.
Kawasaki G; Yanamoto S; Yoshitomi I; Yamada S; Mizuno A
Int J Oral Maxillofac Surg; 2008 Nov; 37(11):1039-46. PubMed ID: 18640824
[TBL] [Abstract][Full Text] [Related]
31. The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis.
Fu J; Qin L; He T; Qin J; Hong J; Wong J; Liao L; Xu J
Cell Res; 2011 Feb; 21(2):275-89. PubMed ID: 20714342
[TBL] [Abstract][Full Text] [Related]
32. Metastasis-associated protein 1 and its short form variant stimulates Wnt1 transcription through promoting its derepression from Six3 corepressor.
Kumar R; Balasenthil S; Manavathi B; Rayala SK; Pakala SB
Cancer Res; 2010 Aug; 70(16):6649-58. PubMed ID: 20682799
[TBL] [Abstract][Full Text] [Related]
33. MTA1 promotes the invasion and migration of pancreatic cancer cells potentially through the HIF-α/VEGF pathway.
Sun X; Zhang Y; Li B; Yang H
J Recept Signal Transduct Res; 2018 Aug; 38(4):352-358. PubMed ID: 30396299
[TBL] [Abstract][Full Text] [Related]
34. Poly(ADP-ribosyl)ation of p53 induces gene-specific transcriptional repression of MTA1.
Lee MH; Na H; Kim EJ; Lee HW; Lee MO
Oncogene; 2012 Dec; 31(49):5099-107. PubMed ID: 22286760
[TBL] [Abstract][Full Text] [Related]
35. MTA1-mediated transcriptional repression of SMAD7 in breast cancer cell lines.
Salot S; Gude R
Eur J Cancer; 2013 Jan; 49(2):492-9. PubMed ID: 22841502
[TBL] [Abstract][Full Text] [Related]
36. Acetylation-dependent oncogenic activity of metastasis-associated protein 1 co-regulator.
Ohshiro K; Rayala SK; Wigerup C; Pakala SB; Natha RS; Gururaj AE; Molli PR; Månsson SS; Ramezani A; Hawley RG; Landberg G; Lee NH; Kumar R
EMBO Rep; 2010 Sep; 11(9):691-7. PubMed ID: 20651739
[TBL] [Abstract][Full Text] [Related]
37. JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI.
Li LL; Xue AM; Li BX; Shen YW; Li YH; Luo CL; Zhang MC; Jiang JQ; Xu ZD; Xie JH; Zhao ZQ
Breast Cancer Res; 2014 May; 16(3):R56. PubMed ID: 24886710
[TBL] [Abstract][Full Text] [Related]
38. MTA1 expression correlates significantly with ER-alpha methylation in breast cancer.
Mao XY; Chen H; Wang H; Wei J; Liu C; Zheng HC; Yao F; Jin F
Tumour Biol; 2012 Oct; 33(5):1565-72. PubMed ID: 22644675
[TBL] [Abstract][Full Text] [Related]
39. Repression of 92-kDa type IV collagenase expression by MTA1 is mediated through direct interactions with the promoter via a mechanism, which is both dependent on and independent of histone deacetylation.
Yan C; Wang H; Toh Y; Boyd DD
J Biol Chem; 2003 Jan; 278(4):2309-16. PubMed ID: 12431981
[TBL] [Abstract][Full Text] [Related]
40. MTA1, a transcriptional activator of breast cancer amplified sequence 3.
Gururaj AE; Singh RR; Rayala SK; Holm C; den Hollander P; Zhang H; Balasenthil S; Talukder AH; Landberg G; Kumar R
Proc Natl Acad Sci U S A; 2006 Apr; 103(17):6670-5. PubMed ID: 16617102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
